Access Equity Research

News

Virtual & In-person Roadshows / Conferences

Channelchek Premium. Access more at no cost. 

The site "channelcheck" is opened on the phone

Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost. 

Access to Exclusive Content. FREE for Registered Users Only. 

Click “Log In” to agree to Channelchek.com <a href="#">Terms of Use</a> and acknowledge that Channelchek.com <a href="#">Privacy Policy</a> applies to you.

Welcome to the Channelchek Investor Community

Informed investors make more money. And it’s all about timing. Get it when it happens.

Inbox Intel from Channelchek.

Release - NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives

NanoViricides

NNVC

<figure class="wp-block-image aligncenter is-resized"><img src="https://ml.globenewswire.com/media/5e2f90ec-c9a5-4fcd-99c8-2c8c838ac033/small/eledon-logo-1230-png.png" alt="Primary Logo" style="aspect-ratio:3.9473684210526314;width:150px;height:auto"/></figure>



<a href="https://www.channelchek.com/company/eldn">Research News and Market Data on ELDN </a>



October 5, 2026



<a href="https://ir.eledon.com/node/11291/pdf" target="_blank" rel="noopener">PDF Version</a>



IRVINE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced an oral presentation will be featured at the upcoming American Society of Nephrology Kidney Week 2026 Annual Meeting taking place in Denver, CO, from October 21-25, 2026. The oral presentation will highlight patient-reported outcomes from the Phase 2 BESTOW trial evaluating tegoprubart for the prevention of rejection in kidney transplantation.



Details of the presentation are below:



Title:&nbsp;Patient-Reported Outcomes in the Phase 2 BESTOW Trial Comparing Tegoprubart to Tacrolimus in Kidney Transplant Recipients



Presenter:&nbsp;Andrew B. Adams, M.D., Ph.D., Department of Surgery,&nbsp;University of Minnesota Medical School; Minneapolis, Minnesota



Abstract Publication Number: FR-OR084



Session Title:&nbsp;The Changing Landscape of Kidney Transplantation: Clinical Innovation, Outcomes, and Healthy Policy



Session Date and Time:&nbsp;Friday, October 23, 2026, from 4:30PM to 6:00PM MDT



Session Room:&nbsp;Mile High Ballroom 4A (Convention Center)



Presentation Time:&nbsp;4:40PM to 4:50 PM MDT



About&nbsp;Eledon Pharmaceuticals&nbsp;and tegoprubart



Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company that is developing immune-modulating therapies for the management and treatment of life-threatening conditions. The Company’s lead investigational product is tegoprubart, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential. The central role of CD40L signaling in both adaptive and innate immune cell activation and function positions it as an attractive target for non-lymphocyte depleting, immunomodulatory therapeutic intervention. The Company is building upon a deep historical knowledge of anti-CD40L biology to conduct preclinical and clinical studies in kidney allograft transplantation, xenotransplantation, islet cell transplantation, liver transplantation and amyotrophic lateral sclerosis (ALS). Eledon is headquartered in Irvine, California. For more information, please visit the Company’s website at <a href="https://www.globenewswire.com/Tracker?data=FM474jwVDYKsM3VbqsF8tNWz-nJ-6la7hm3pMZhEa6ug-NtMpnkLzD1OHaZ4MC-Up_0XyLaOzqnFZRRkOz9SEQ==" rel="noopener" target="_blank">www.eledon.com</a>.



Follow&nbsp;Eledon Pharmaceuticals&nbsp;on social media:&nbsp;<a href="https://www.globenewswire.com/Tracker?data=XlDUqm8697Co0fE0YtfVSZHmwXJuplU3l1a7DeggZuJWQRt8IFk55XamFaIpQPABbPOPmD_Ak5kXaOVjbNszwasNyPAwgS04d3dIB6EQ_sYpIZea7l7zdG14r8ZAeRY4" rel="noopener" target="_blank">LinkedIn</a>;&nbsp;<a href="https://www.globenewswire.com/Tracker?data=C8GAec5PEVBTGO3cKI160nrNFFEl7d-XoHpZonWET0MdRCE0Jf0PUd1byvRCd48lNxm3zimP1__1PiicerlE6g==" rel="noopener" target="_blank">X</a>



Investor Contact:



Stephen Jasper Gilmartin Group (858) 525 2047 <a href="https://www.globenewswire.com/Tracker?data=ii4e7NdvrcQKK3zRwgn9uhcEAnguMYDVaJkAF6MdthrOfNV770J_gjAvZW00F_8Q-mCdr0HXBY8jAWVnLp3AfxCglyG50wzqQWByGbQeSP88RvVn7iW3Ea7jsSJTVMCM" rel="noopener" target="_blank">stephen@gilmartinir.com</a>



Media Contact:



Jenna Urban CG Life (212) 253 8881 <a href="https://www.globenewswire.com/Tracker?data=wIOnBQBtiWvft3yhXj0NsRgCs1x0-0RvwSjxe53wmarw03dV2NhVsUT4EEnW7VXXrGNnSGRFaFfbLkAyz51g0tvryX-fFmqXwIJM84fMdxg=" rel="noopener" target="_blank">jurban@cglife.com</a>

Research News and Market Data on ELDN 



October 5, 2026



PDF Version



IRVINE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) &#8212; Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced an oral presentation will be featured at the upcoming American Society of Nephrology Kidney Week 2026 Annual Meeting taking place in Denver, CO, from October 21-25, 2026. The oral presentation will highlight patient-reported outcomes from the Phase 2 BESTOW trial evaluating tegoprubart for the prevention of rejection in kidney transplantation.



Details of the presentation are below:



Title:&nbsp;Patient-Reported Outcomes in the Phase 2 BESTOW Trial Comparing Tegoprubart to Tacrolimus in Kidney Transplant Recipients



Presenter:&nbsp;Andrew B. Adams, M.D., Ph.D., Department of Surgery,&nbsp;University of Minnesota Medical School; Minneapolis, Minnesota



Abstract Publication Number: FR-OR084



Session Title:&nbsp;The Changing Landscape of Kidney Transplantation: Clinical Innovation, Outcomes, and Healthy Policy



Session Date and Time:&nbsp;Friday, October 23, 2026, from 4:30PM to 6:00PM MDT



Session Room:&nbsp;Mile High Ballroom 4A (Convention Center)



Presentation Time:&nbsp;4:40PM to 4:50 PM MDT



About&nbsp;Eledon Pharmaceuticals&nbsp;and tegoprubart



Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company that is developing immune-modulating therapies for the management and treatment of life-threatening conditions. The Company’s lead investigational product is tegoprubart, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential. The central role of CD40L signaling in both adaptive and innate immune cell activation and function positions it as an attractive target for non-lymphocyte depleting, immunomodulatory therapeutic intervention. The Company is building upon a deep historical knowledge of anti-CD40L biology to conduct preclinical and clinical studies in kidney allograft transplantation, xenotransplantation, islet cell transplantation, liver transplantation and amyotrophic lateral sclerosis (ALS). Eledon is headquartered in Irvine, California. For more information, please visit the Company’s website at www.eledon.com.



Follow&nbsp;Eledon Pharmaceuticals&nbsp;on social media:&nbsp;LinkedIn;&nbsp;X



Investor Contact:



Stephen JasperGilmartin Group(858) 525 2047stephen@gilmartinir.com



Media Contact:



Jenna UrbanCG Life(212) 253 8881jurban@cglife.com

Release - Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting

eldn

Eledon Pharmaceuticals

<figure class="wp-block-image aligncenter"><a class="logo" href="https://www.tectonicmetals.com/"><img src="https://www.tectonicmetals.com/_resources/images/footerLogo.svg" alt="Tectonic Metals Logo"/></a></figure>



<a href="https://www.channelchek.com/company/tetof">Research News and Market Data on TETOF</a>



<a href="https://www.tectonicmetals.com/_resources/news/nr-20261005.pdf" target="_blank" rel="noopener">Download the PDF</a>



VANCOUVER, B.C., October 5, 2026 – Tectonic Metals Inc. (“Tectonic” or the “Company”) (TSX-V: TECT; OTCQX: TETOF) is pleased to announce the appointment of Eduard Epshtein, CPA, CA, as Chief Financial Officer (“CFO”) and Corporate Secretary, effective October 1, 2026.



Mr. Epshtein brings more than two decades of experience spanning capital markets, project development, strategic transactions and corporate finance. He joins Tectonic following a 16-year tenure as CFO of Lithium Americas Corp., where he helped build the company from an exploration-stage start-up into an NYSE-listed lithium producer with a market capitalization that exceeded US$5&nbsp;billion.



His appointment comes at a pivotal stage as Tectonic advances its flagship Flat Gold Project in southwest Alaska, U.S., with a number of key catalysts ahead, including the completion of its largest-ever drill program at the end of October, a maiden Mineral Resource Estimate for the Chicken Mountain intrusion target planned for the first quarter of 2027, followed by a Preliminary Economic Assessment (“PEA”) targeted for the second quarter of 2027.



Tony Reda, Co-Founder, President and CEO, commented:



“Eduard has already helped build what we are now building at Tectonic. He has taken a resource company from exploration through development and into production and understands first-hand what each stage demands – from capital and corporate infrastructure to governance, strategic partnerships and execution. Having helped guide Lithium Americas from the TSX Venture Exchange to the TSX and ultimately the NYSE, while advancing major projects and completing significant financings and transactions, he brings experience that is directly aligned with the road ahead for our Company.



“While that experience will be valuable as we advance Flat and consider our future capital markets strategy, it is Eduard’s character that stands out most: he shares our long-term approach to building Tectonic and brings loyalty, integrity and commitment to the team. We are thrilled to welcome him.”



Proven Capital Markets and Corporate Leadership Experience



As CFO of Lithium Americas Corp. from its formation in 2007 through 2023, Mr. Epshtein helped build the company from an exploration-stage start-up with a small team into a major publicly traded lithium producer. During his tenure, Lithium Americas completed its initial public offering on the TSX Venture Exchange in 2008, graduated to the Toronto Stock Exchange in 2011 and listed on the New York Stock Exchange in 2018. He subsequently played a central support role in the separation of Lithium Americas into two independent public companies, including the NYSE listing of Lithium Argentina.



Mr. Epshtein also brings extensive experience advancing large-scale resource projects through successive stages of development. He helped advance the Cauchari-Olaroz lithium project in Argentina from exploration through construction and into production, with a design capacity of 40,000 tonnes per annum and approximately US$1 billion of construction capital. He was also involved in advancing the Thacker Pass project in Nevada from exploration into construction, including the development of a multi-billion-dollar funding strategy involving the U.S. Department of Energy and General Motors.



Throughout his career, Mr. Epshtein has executed a broad range of financings and strategic transactions, including project financing, convertible debt, at-the-market offerings, strategic investments, offtake arrangements and royalties. His experience also includes structuring joint ventures and strategic arrangements involving SQM, Ganfeng Lithium and General Motors, as well as significant M&amp;A transactions, including the Western Lithium–Lithium Americas merger and the acquisitions of Millennial Lithium and Arena Minerals.



Beyond capital markets and project development, Mr. Epshtein brings broad public-company leadership experience. At various stages of Lithium Americas' growth, he was responsible for financial reporting, finance, treasury, risk management, internal controls, information technology, corporate secretary functions, ESG reporting, Board support, as well as legal and human resources.



Eduard Epshtein commented:



“Tectonic has reached an exciting stage in its evolution. I have spent much of my career helping build and advance resource companies through periods of significant growth, and I see many of the same ingredients here: a compelling project, an experienced and ambitious team, a strong financial position and a clear long-term vision.



“What attracted me most to Tectonic is the opportunity to help build something meaningful and exciting. I look forward to working with Tony, the Board and the entire Tectonic team as we advance Flat and build the financial, corporate and capital markets foundation to support the Company through its next stage of growth.”



Chief Financial Officer and Corporate Secretary Transition



The Company also announces that Oliver Foeste has stepped down as the Company’s CFO and Corporate Secretary, effective October 1, 2026.



“I want to sincerely thank Oliver for his contributions over the past four years and for the partnership, counsel and friendship we have shared,” added Mr. Reda. “He helped the Company navigate a significant period of growth, including its financings, public company reporting requirements and governance. We are grateful for his contributions to Tectonic and wish him every success in the future.”



Stock Option Grant and Restricted Share Unit Grant



Separately, the Company announces the following grants under its Equity Incentive Plan.



A total of 560,000 incentive stock options have been granted to an officer and an employee of the Company to purchase up to 560,000 common shares (“Option Shares”) in the capital of Tectonic.



The stock options have an exercise price of C$2.05 per Option Share, expire five years from the grant date and vest over a 36-month period in three equal installments every twelve months from the grant date.



A total of 51,000 restricted share units (“RSUs”) have been granted to an officer of the Company. The RSUs vest over a 36-month period in three equal installments every twelve months from the grant date.



About Tectonic Metals Inc.



Tectonic Metals Inc. is a mineral exploration company led by an experienced and well-respected technical and financial team with a track record of wealth creation for shareholders. The Company is focused on exploring and developing its flagship Flat Gold Project in southwestern Alaska, covering 99,840 acres of predominantly Native-owned land belonging to Doyon, Ltd., a leading Alaska Native Regional Corporation and one of Tectonic’s largest shareholders. The current focus is on advancing the Chicken Mountain target, one of six multi-kilometre-scale intrusion zones at the Flat Gold Project, where drilling has achieved a 100% success rate across 206 holes to date.



Founded by key members of the Kaminak Gold team behind the discovery and advancement of the Coffee Gold Project, which was acquired by Goldcorp for $520 million in 2016, Tectonic brings a proven track record in exploration, project advancement, capital markets and value creation. Collectively, the team has helped identify 40 million ounces of gold, advanced more than 20&nbsp;projects through to feasibility, permitted 25 projects, completed over $6 billion in mergers and acquisitions and raised more than $6 billion in capital.



Tectonic’s mission is to be a shift in the game: working for our shareholders and the communities where we operate, putting people first, playing big and staying true to our word every step of the way.



On behalf of Tectonic Metals Inc.,&nbsp;&nbsp;



Tony Reda, President and Chief Executive Officer&nbsp;&nbsp;



For further information about Tectonic Metals Inc. or this news release, please visit our website at www.tectonicmetals.com or contact:



Keren Yun Vice President, Investor Relations 1-888-685-8558 or <a href="mailto:investorrelations@tectonicmetals.com">investorrelations@tectonicmetals.com</a>.



Cautionary Note Regarding Forward-Looking Statements, Historical Information and Visual Observations



This news release contains “forward-looking statements” and “forward-looking information” (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities laws. All statements herein that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often, but not always, identified by words such as “may,” “will,” “should,” “anticipate,” “believe,” “expect,” “intend,” “plan,” “estimate,” “potential,” “target,” or similar terminology, or that events or conditions “may” or “will” occur.



Forward-looking statements in this release include, but are not limited to, statements regarding: the ability of Mr. Epshtein to apply his prior work experience and knowledge to assist with the Company’s growth strategy, the potential for mineralization at Tectonic’s projects; the nature, scope, and timing of future exploration activities; the interpretation of geological observations; the possible size or scale of mineralized systems; the receipt of regulatory approvals, and the anticipated benefits of current and future exploration programs.



This release also refers to historical information, including results from past exploration activities and placer production figures. Such historical information has not been independently verified by Tectonic, may not be reliable, and should not be relied upon as current, NI 43-101 compliant data.



In addition, this release contains, detailed geological notes, and descriptive observations such as alteration styles, mineralogy and visible gold. These observations are preliminary in nature, may not be representative of the entire interval or system, and should not be relied upon as a guarantee of mineralized assay results or as the basis for any investment decision. Investors and readers are cautioned that visual estimates, core photographs, and geological descriptions are not substitutes for laboratory assay results and do not demonstrate the economic viability of any mineral deposit.



Forward-looking statements are not guarantees of future performance. They are based on a number of assumptions made as of the date such statements are provided, including, among others: assumptions regarding future gold and other metal prices; currency exchange and interest rates; favourable operating and political conditions; timely receipt of permits and regulatory approvals; availability of labour, equipment, and services; stability of financial and capital markets; availability of financing on acceptable terms; accuracy of exploration data and geological models; and the ability to successfully advance planned exploration programs. Many of these assumptions are beyond the control of Tectonic and may prove to be incorrect.



Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied. These risks include, without limitation: risks inherent to mineral exploration and development; volatility of commodity prices; changes in laws, regulations, and policies; delays or inability to obtain required approvals and permits; availability of financing; general economic, political, and market conditions; labour disputes and shortages; equipment and supply risks; environmental and social risks; competition; inaccuracies in exploration results or geological interpretations; and other risks detailed from time to time in the Company’s continuous disclosure filings.



Although management believes the expectations expressed in such forward-looking statements are reasonable as of the date made, there can be no assurance they will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements, historical information, or preliminary visual geological observations. Actual results and future events may differ materially from those anticipated. All forward-looking statements contained in this news release are expressly qualified by this cautionary statement. Tectonic disclaims any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws.&nbsp;



Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. &nbsp;

Research News and Market Data on TETOF



Download the PDF



VANCOUVER, B.C., October 5, 2026 – Tectonic Metals Inc. (“Tectonic” or the “Company”) (TSX-V: TECT; OTCQX: TETOF) is pleased to announce the appointment of Eduard Epshtein, CPA, CA, as Chief Financial Officer (“CFO”) and Corporate Secretary, effective October 1, 2026.



Mr. Epshtein brings more than two decades of experience spanning capital markets, project development, strategic transactions and corporate finance. He joins Tectonic following a 16-year tenure as CFO of Lithium Americas Corp., where he helped build the company from an exploration-stage start-up into an NYSE-listed lithium producer with a market capitalization that exceeded US$5&nbsp;billion.



His appointment comes at a pivotal stage as Tectonic advances its flagship Flat Gold Project in southwest Alaska, U.S., with a number of key catalysts ahead, including the completion of its largest-ever drill program at the end of October, a maiden Mineral Resource Estimate for the Chicken Mountain intrusion target planned for the first quarter of 2027, followed by a Preliminary Economic Assessment (“PEA”) targeted for the second quarter of 2027.



Tony Reda, Co-Founder, President and CEO, commented:



“Eduard has already helped build what we are now building at Tectonic. He has taken a resource company from exploration through development and into production and understands first-hand what each stage demands – from capital and corporate infrastructure to governance, strategic partnerships and execution. Having helped guide Lithium Americas from the TSX Venture Exchange to the TSX and ultimately the NYSE, while advancing major projects and completing significant financings and transactions, he brings experience that is directly aligned with the road ahead for our Company.



“While that experience will be valuable as we advance Flat and consider our future capital markets strategy, it is Eduard’s character that stands out most: he shares our long-term approach to building Tectonic and brings loyalty, integrity and commitment to the team. We are thrilled to welcome him.”



Proven Capital Markets and Corporate Leadership Experience



As CFO of Lithium Americas Corp. from its formation in 2007 through 2023, Mr. Epshtein helped build the company from an exploration-stage start-up with a small team into a major publicly traded lithium producer. During his tenure, Lithium Americas completed its initial public offering on the TSX Venture Exchange in 2008, graduated to the Toronto Stock Exchange in 2011 and listed on the New York Stock Exchange in 2018. He subsequently played a central support role in the separation of Lithium Americas into two independent public companies, including the NYSE listing of Lithium Argentina.



Mr. Epshtein also brings extensive experience advancing large-scale resource projects through successive stages of development. He helped advance the Cauchari-Olaroz lithium project in Argentina from exploration through construction and into production, with a design capacity of 40,000 tonnes per annum and approximately US$1 billion of construction capital. He was also involved in advancing the Thacker Pass project in Nevada from exploration into construction, including the development of a multi-billion-dollar funding strategy involving the U.S. Department of Energy and General Motors.



Throughout his career, Mr. Epshtein has executed a broad range of financings and strategic transactions, including project financing, convertible debt, at-the-market offerings, strategic investments, offtake arrangements and royalties. His experience also includes structuring joint ventures and strategic arrangements involving SQM, Ganfeng Lithium and General Motors, as well as significant M&amp;A transactions, including the Western Lithium–Lithium Americas merger and the acquisitions of Millennial Lithium and Arena Minerals.



Beyond capital markets and project development, Mr. Epshtein brings broad public-company leadership experience. At various stages of Lithium Americas&#8217; growth, he was responsible for financial reporting, finance, treasury, risk management, internal controls, information technology, corporate secretary functions, ESG reporting, Board support, as well as legal and human resources.



Eduard Epshtein commented:



“Tectonic has reached an exciting stage in its evolution. I have spent much of my career helping build and advance resource companies through periods of significant growth, and I see many of the same ingredients here: a compelling project, an experienced and ambitious team, a strong financial position and a clear long-term vision.



“What attracted me most to Tectonic is the opportunity to help build something meaningful and exciting. I look forward to working with Tony, the Board and the entire Tectonic team as we advance Flat and build the financial, corporate and capital markets foundation to support the Company through its next stage of growth.”



Chief Financial Officer and Corporate Secretary Transition



The Company also announces that Oliver Foeste has stepped down as the Company’s CFO and Corporate Secretary, effective October 1, 2026.



“I want to sincerely thank Oliver for his contributions over the past four years and for the partnership, counsel and friendship we have shared,” added Mr. Reda. “He helped the Company navigate a significant period of growth, including its financings, public company reporting requirements and governance. We are grateful for his contributions to Tectonic and wish him every success in the future.”



Stock Option Grant and Restricted Share Unit Grant



Separately, the Company announces the following grants under its Equity Incentive Plan.



A total of 560,000 incentive stock options have been granted to an officer and an employee of the Company to purchase up to 560,000 common shares (“Option Shares”) in the capital of Tectonic.



The stock options have an exercise price of C$2.05 per Option Share, expire five years from the grant date and vest over a 36-month period in three equal installments every twelve months from the grant date.



A total of 51,000 restricted share units (“RSUs”) have been granted to an officer of the Company. The RSUs vest over a 36-month period in three equal installments every twelve months from the grant date.



About Tectonic Metals Inc.



Tectonic Metals Inc. is a mineral exploration company led by an experienced and well-respected technical and financial team with a track record of wealth creation for shareholders. The Company is focused on exploring and developing its flagship Flat Gold Project in southwestern Alaska, covering 99,840 acres of predominantly Native-owned land belonging to Doyon, Ltd., a leading Alaska Native Regional Corporation and one of Tectonic’s largest shareholders. The current focus is on advancing the Chicken Mountain target, one of six multi-kilometre-scale intrusion zones at the Flat Gold Project, where drilling has achieved a 100% success rate across 206 holes to date.



Founded by key members of the Kaminak Gold team behind the discovery and advancement of the Coffee Gold Project, which was acquired by Goldcorp for $520 million in 2016, Tectonic brings a proven track record in exploration, project advancement, capital markets and value creation. Collectively, the team has helped identify 40 million ounces of gold, advanced more than 20&nbsp;projects through to feasibility, permitted 25 projects, completed over $6 billion in mergers and acquisitions and raised more than $6 billion in capital.



Tectonic’s mission is to be a shift in the game: working for our shareholders and the communities where we operate, putting people first, playing big and staying true to our word every step of the way.



On behalf of Tectonic Metals Inc.,&nbsp;&nbsp;



Tony Reda, President and Chief Executive Officer&nbsp;&nbsp;



For further information about Tectonic Metals Inc. or this news release, please visit our website at www.tectonicmetals.com or contact:



Keren YunVice President, Investor Relations1-888-685-8558 or investorrelations@tectonicmetals.com.



Cautionary Note Regarding Forward-Looking Statements, Historical Information and Visual Observations



This news release contains “forward-looking statements” and “forward-looking information” (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities laws. All statements herein that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often, but not always, identified by words such as “may,” “will,” “should,” “anticipate,” “believe,” “expect,” “intend,” “plan,” “estimate,” “potential,” “target,” or similar terminology, or that events or conditions “may” or “will” occur.



Forward-looking statements in this release include, but are not limited to, statements regarding: the ability of Mr. Epshtein to apply his prior work experience and knowledge to assist with the Company’s growth strategy, the potential for mineralization at Tectonic’s projects; the nature, scope, and timing of future exploration activities; the interpretation of geological observations; the possible size or scale of mineralized systems; the receipt of regulatory approvals, and the anticipated benefits of current and future exploration programs.



This release also refers to historical information, including results from past exploration activities and placer production figures. Such historical information has not been independently verified by Tectonic, may not be reliable, and should not be relied upon as current, NI 43-101 compliant data.



In addition, this release contains, detailed geological notes, and descriptive observations such as alteration styles, mineralogy and visible gold. These observations are preliminary in nature, may not be representative of the entire interval or system, and should not be relied upon as a guarantee of mineralized assay results or as the basis for any investment decision. Investors and readers are cautioned that visual estimates, core photographs, and geological descriptions are not substitutes for laboratory assay results and do not demonstrate the economic viability of any mineral deposit.



Forward-looking statements are not guarantees of future performance. They are based on a number of assumptions made as of the date such statements are provided, including, among others: assumptions regarding future gold and other metal prices; currency exchange and interest rates; favourable operating and political conditions; timely receipt of permits and regulatory approvals; availability of labour, equipment, and services; stability of financial and capital markets; availability of financing on acceptable terms; accuracy of exploration data and geological models; and the ability to successfully advance planned exploration programs. Many of these assumptions are beyond the control of Tectonic and may prove to be incorrect.



Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied. These risks include, without limitation: risks inherent to mineral exploration and development; volatility of commodity prices; changes in laws, regulations, and policies; delays or inability to obtain required approvals and permits; availability of financing; general economic, political, and market conditions; labour disputes and shortages; equipment and supply risks; environmental and social risks; competition; inaccuracies in exploration results or geological interpretations; and other risks detailed from time to time in the Company’s continuous disclosure filings.



Although management believes the expectations expressed in such forward-looking statements are reasonable as of the date made, there can be no assurance they will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements, historical information, or preliminary visual geological observations. Actual results and future events may differ materially from those anticipated. All forward-looking statements contained in this news release are expressly qualified by this cautionary statement. Tectonic disclaims any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws.&nbsp;



Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. &nbsp;

Release - Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth

Tectonic Metals

TETOF

<figure class="wp-block-image aligncenter is-resized"><img src="https://ml.globenewswire.com/media/cd9c5396-aa7a-4bcd-b73b-7e649095bbe1/small/kratos-logo-plain-jpg.JPG" alt="Primary Logo" style="width:194px;height:auto"/></figure>



<a href="https://www.channelchek.com/company/ktos">Research News and Market Data on KTOS</a> 



October 5, 2026



<a href="https://ir.kratosdefense.com/node/33106/pdf" target="_blank" rel="noopener">PDF Version</a>



SAN DIEGO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kratos Defense &amp; Security Solutions, Inc. (Nasdaq: KTOS), a technology company in defense, national security, and global markets, today announced multiple contract awards totaling over $100 million to develop prototype mission applications and cyber capabilities providing space intelligence data in support of joint operations across the space and cyberspace domains.



Work under the contracts will provide warfighters with capabilities to collect and process complex radio frequency (RF) signals, develop intelligence on the operational environment and support the joint targeting cycle – the process used to identify, prioritize and target assets. The prototype systems will support electronic warfare and offensive cyber operations, including capabilities for access and battle damage assessment.



The work leverages the KnownSpace® Network, Kratos’ global RF collection infrastructure consisting of more than 190 strategically placed sensors around the world, along with RF data and capabilities provided by KnownSpace Recon+™, Kratos’ field-portable space domain awareness (SDA) terminals. In addition, the contracts will leverage Kratos’ software products, analytics and expertise in RF, signal processing, cybersecurity and software development, establishing a proven technology base that can be adapted and integrated to meet emerging space and cyber mission requirements.



“Kratos brings decades of space experience together with proven commercial technology and agile engineering to solve some of today’s most complex mission challenges,” said Greg Caicedo, Senior Vice President at Kratos. “Our systems, software and hardware support missions across SDA, command &amp; control, satellite operations and cybersecurity. By building on proven technology and rapidly adapting it to emerging mission needs, we can deliver new capabilities faster and keep pace as the space environment changes.”



The Kratos KnownSpace family of SDA products and services which support these awards provide deep insights for global, sovereign, and tactical operations. Built on more than 30 years of satellite monitoring and RF expertise, the KnownSpace family combines global RF sensing, software, managed operations and deployable systems to detect, characterize and understand satellite and terrestrial activity. Solutions include enterprise software applications, portable form factors that can be deployed anywhere and persistent global RF signal monitoring and geolocation through its KnownSpace Network of over 20 locations and 190 sensors worldwide—the largest commercially owned, commercially operated (COCO) RF sensor network.



Due to security related, competitive and other considerations, no additional information will be provided.



About Kratos Defense &amp; Security Solutions Kratos Defense &amp; Security Solutions, Inc. (NASDAQ: KTOS) is a technology, products, system and software company addressing the defense, national security, and commercial markets. Kratos makes true internally funded research, development, capital and other investments, to rapidly develop, produce and field solutions that address our customers’ mission critical needs and requirements. At Kratos, affordability is a technology, and we seek to utilize proven, leading-edge approaches and technology, not unproven bleeding edge approaches or technology, with Kratos’ approach designed to reduce cost, schedule and risk, enabling us to be first to market with cost effective solutions. We believe that Kratos is known as an innovative disruptive change agent in the industry, a company that is an expert in designing products and systems up front for successful rapid, large quantity, low- cost future manufacturing which is a value-add competitive differentiator for our large traditional prime system integrator partners and also to our government and commercial customers. Kratos intends to pursue program and contract opportunities as the prime or lead contractor when we believe that our probability of win (PWin) is high and any investment required by Kratos is within our capital resource comfort level. We intend to partner and team with a large, traditional system integrator when our assessment of PWin is greater or required investment is beyond Kratos’ comfort level. Kratos’ primary business areas include virtualized ground systems for satellites and space vehicles including software for command &amp; control (C2) and telemetry, tracking and control (TT&amp;C), jet powered unmanned aerial drone systems, hypersonic vehicles and rocket systems, propulsion systems for drones, missiles, loitering munitions, supersonic systems, space craft and launch systems, C5ISR and microwave electronic products for missile, radar, missile defense, space, satellite, counter UAS, directed energy, communication and other systems, and virtual &amp; augmented reality training systems for the warfighter. For more information, visit <a href="https://www.globenewswire.com/Tracker?data=_JDW6ljZTNKY0lgt2ZD9B_4ABXOrNOsqXli_W-bHczBDwtnO3T625Je1UD0xMDCMgjsUOmqNxsnH789FOqxp0xV80i7ajlVxXCwAl7G6uIs=" rel="noopener" target="_blank">www.KratosDefense.com</a> and follow Kratos on&nbsp;<a href="https://www.globenewswire.com/Tracker?data=3qC98WiwsPXVTU-lDTJrChKRnLZUl7a7nkxwKfmzkyg1E4irG9j4Zdw-KrIaTryIqPblcozzpiXoFhplzP2ENjuz3iIRbuGlmYZ0q4b31Rj-Hgo__sMxaet69iS1W14eV1GDj9OQnek31AnDcjQqUw==" rel="noopener" target="_blank">LinkedIn</a> and <a href="https://www.globenewswire.com/Tracker?data=bOu_eu4jj7KEtEvRBBzJxAqPV722zLXV0TDvdzevKMqShyzt-hiyA9yhmDZ2YqAkpmxGwrP_th0k5ND8H2XCSQ==" rel="noopener" target="_blank">X</a>.



Notice Regarding Forward-Looking Statements Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended December 29, 2025, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by Kratos.



Press Contact: Claire Cantrell <a href="https://www.globenewswire.com/Tracker?data=77K1LEaqFa0TAr3T6StMosQEbppMUKMEysiKwt9806QsJj5hCGs82GNhG3TeQhTRc5VIiWdL34t3OjY51fV-UJMBPOdpckDCSwL8lztoG0KZ3IoOQLOZi3UUw2NRefuUC1JElt0CQsXBAzeEWx6qwA==" rel="noopener" target="_blank">claire.cantrell@kratosdefense.com</a>



Kratos Investor Information: 877-934-4687 <a href="https://www.globenewswire.com/Tracker?data=kCwzNwE1wXrEDHDKEUhv2A_qDqeJrPdzIOzNWAyPNjxIlx8aPElQE2d2Tk-as9C9BGw0ndGBkgiK1ucJOmxFl_CQLfUAGPgpgIwYHE_IaZxd9nPyFOD5Sif9XtN1Zr8z" rel="noopener" target="_blank">investor@kratosdefense.com</a>

Research News and Market Data on KTOS 



October 5, 2026



PDF Version



SAN DIEGO, Oct. 05, 2026 (GLOBE NEWSWIRE) &#8212; Kratos Defense &amp; Security Solutions, Inc. (Nasdaq: KTOS), a technology company in defense, national security, and global markets, today announced multiple contract awards totaling over $100 million to develop prototype mission applications and cyber capabilities providing space intelligence data in support of joint operations across the space and cyberspace domains.



Work under the contracts will provide warfighters with capabilities to collect and process complex radio frequency (RF) signals, develop intelligence on the operational environment and support the joint targeting cycle – the process used to identify, prioritize and target assets. The prototype systems will support electronic warfare and offensive cyber operations, including capabilities for access and battle damage assessment.



The work leverages the KnownSpace® Network, Kratos’ global RF collection infrastructure consisting of more than 190 strategically placed sensors around the world, along with RF data and capabilities provided by KnownSpace Recon+™, Kratos’ field-portable space domain awareness (SDA) terminals. In addition, the contracts will leverage Kratos’ software products, analytics and expertise in RF, signal processing, cybersecurity and software development, establishing a proven technology base that can be adapted and integrated to meet emerging space and cyber mission requirements.



“Kratos brings decades of space experience together with proven commercial technology and agile engineering to solve some of today’s most complex mission challenges,” said Greg Caicedo, Senior Vice President at Kratos. “Our systems, software and hardware support missions across SDA, command &amp; control, satellite operations and cybersecurity. By building on proven technology and rapidly adapting it to emerging mission needs, we can deliver new capabilities faster and keep pace as the space environment changes.”



The Kratos KnownSpace family of SDA products and services which support these awards provide deep insights for global, sovereign, and tactical operations. Built on more than 30 years of satellite monitoring and RF expertise, the KnownSpace family combines global RF sensing, software, managed operations and deployable systems to detect, characterize and understand satellite and terrestrial activity. Solutions include enterprise software applications, portable form factors that can be deployed anywhere and persistent global RF signal monitoring and geolocation through its KnownSpace Network of over 20 locations and 190 sensors worldwide—the largest commercially owned, commercially operated (COCO) RF sensor network.



Due to security related, competitive and other considerations, no additional information will be provided.



About Kratos Defense &amp; Security SolutionsKratos Defense &amp; Security Solutions, Inc. (NASDAQ: KTOS) is a technology, products, system and software company addressing the defense, national security, and commercial markets. Kratos makes true internally funded research, development, capital and other investments, to rapidly develop, produce and field solutions that address our customers’ mission critical needs and requirements. At Kratos, affordability is a technology, and we seek to utilize proven, leading-edge approaches and technology, not unproven bleeding edge approaches or technology, with Kratos’ approach designed to reduce cost, schedule and risk, enabling us to be first to market with cost effective solutions. We believe that Kratos is known as an innovative disruptive change agent in the industry, a company that is an expert in designing products and systems up front for successful rapid, large quantity, low- cost future manufacturing which is a value-add competitive differentiator for our large traditional prime system integrator partners and also to our government and commercial customers. Kratos intends to pursue program and contract opportunities as the prime or lead contractor when we believe that our probability of win (PWin) is high and any investment required by Kratos is within our capital resource comfort level. We intend to partner and team with a large, traditional system integrator when our assessment of PWin is greater or required investment is beyond Kratos’ comfort level. Kratos’ primary business areas include virtualized ground systems for satellites and space vehicles including software for command &amp; control (C2) and telemetry, tracking and control (TT&amp;C), jet powered unmanned aerial drone systems, hypersonic vehicles and rocket systems, propulsion systems for drones, missiles, loitering munitions, supersonic systems, space craft and launch systems, C5ISR and microwave electronic products for missile, radar, missile defense, space, satellite, counter UAS, directed energy, communication and other systems, and virtual &amp; augmented reality training systems for the warfighter. For more information, visit www.KratosDefense.com and follow Kratos on&nbsp;LinkedIn and X.



Notice Regarding Forward-Looking StatementsCertain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended December 29, 2025, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by Kratos.



Press Contact:Claire Cantrellclaire.cantrell@kratosdefense.com



Kratos Investor Information:877-934-4687investor@kratosdefense.com

Release - Kratos Secures More Than $100 Million in Contracts for Space and Cyber Mission Capabilities

Kratos Defense &amp; Security Solutions

KTOS

<figure class="wp-block-image aligncenter is-resized"><img src="https://ir.corecivic.com/sites/g/files/knoqqb21761/themes/site/nir_pid1984/dist/images/coreCivic-logo-19.png" alt="CoreCivic" style="aspect-ratio:3.0940236010658544;width:179px;height:auto"/></figure>



<a href="https://www.channelchek.com/company/cxw">Research News and Market Data on CXW</a>



October 5, 2026



<a href="https://ir.corecivic.com/node/25801/pdf" target="_blank" rel="noopener">PDF Version</a>



BRENTWOOD, Tenn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- CoreCivic, Inc. (NYSE: CXW) ("CoreCivic") announced today that it will release its 2026 third quarter financial results after the market closes on Wednesday, November 4, 2026. A live broadcast of CoreCivic's conference call will begin at 10:00 a.m. central time (11:00 a.m. eastern time) on Thursday, November 5, 2026.



To participate via telephone and join the call live, please register in advance. Upon registration at <a href="https://www.globenewswire.com/Tracker?data=xKLLBx08PiAQHY8GreyUDjz-M9OnPi6TxTcw1n4jnZC5WElPXw55jlHCak0R7xJ6gUpJWqZDmj4vWBXUGAjn0SBLtBPuHw1a1BAqEQWYqNqphDF1JYtiGRWXSMqtXOxQ5KPBGbVaHY1eZ_BUcjkpPwRcoXntNG4jWH3Zy2Hni0NqbZxZH1nMVmv7mU7B_LCw" rel="noopener" target="_blank">https://edge.media-server.com/mmc/p/si7rqqax/lan/en/</a>, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique passcode.



Participants may access the audio-only webcast of the conference call from the Company's website at <a href="https://www.globenewswire.com/Tracker?data=KffTu06fCNcH89IAeuVtJ29P2GrtNf6e_bHgWMjejxdUJ4QlySirqRnIbp0T3D5v9mK6DbxzhqI6Ke01T57acMk9-Bjj1Y8pPoAXJiwmos4=" rel="noopener" target="_blank">www.corecivic.com</a> under the “<a href="https://www.globenewswire.com/Tracker?data=Xzj3SHDQOfhUTv095OYZst9d8HKSgzyB0erHKuOJ192DyxIDqywHdr5Q4NedT_I4aqm0MStPOrynSDnYU3Fo8RwVRoDYvrkLNWFYSogfKUM=" rel="noopener" target="_blank">Events &amp; Presentations</a>” section of the "Investors" page. A replay of the webcast will be available for seven days.



About CoreCivic



CoreCivic is a diversified, government-solutions company with the scale and experience needed to solve tough government challenges in flexible, cost-effective ways. We provide a broad range of solutions to government partners that help build safer, healthier, and more productive communities one person at a time through residential corrections, detention, and reentry management, complementary service offerings to the corrections industry that include pharmaceutical, transportation, and alternatives to incarceration, and government real estate solutions. We are the nation’s largest owner of partnership correctional, detention and residential reentry facilities, and one of the largest operators of such facilities in the United States. We have been a flexible and dependable partner for government for more than 40 years. Our employees are driven by a deep sense of service, high standards of professionalism and a responsibility to help government better the public good. Learn more at <a href="https://www.globenewswire.com/Tracker?data=KffTu06fCNcH89IAeuVtJ8Mi2SrweEmZA2AcHUha8RTewG-JklvPDoym3qZL7WPDIYnA7mn0AR3LZX9fyrbUhElesmGofFrdRwm77Q-8eNw=" rel="noopener" target="_blank">www.corecivic.com</a>.



<figure class="wp-block-table"><table class="has-fixed-layout"><tbody><tr><td>Contact:</td><td>&nbsp;&nbsp;</td><td>Investors: Jeb Bachmann – Managing Director, Investor Relations - (615) 263-3024 Media: Steve Owen – Vice President, Communications - (615) 263-3107</td></tr></tbody></table></figure>

Research News and Market Data on CXW



October 5, 2026



PDF Version



BRENTWOOD, Tenn., Oct. 05, 2026 (GLOBE NEWSWIRE) &#8212; CoreCivic, Inc. (NYSE: CXW) (&#8220;CoreCivic&#8221;) announced today that it will release its 2026 third quarter financial results after the market closes on Wednesday, November 4, 2026. A live broadcast of CoreCivic&#8217;s conference call will begin at 10:00 a.m. central time (11:00 a.m. eastern time) on Thursday, November 5, 2026.



To participate via telephone and join the call live, please register in advance. Upon registration at https://edge.media-server.com/mmc/p/si7rqqax/lan/en/, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique passcode.



Participants may access the audio-only webcast of the conference call from the Company&#8217;s website at www.corecivic.com under the “Events &amp; Presentations” section of the &#8220;Investors&#8221; page. A replay of the webcast will be available for seven days.



About CoreCivic



CoreCivic is a diversified, government-solutions company with the scale and experience needed to solve tough government challenges in flexible, cost-effective ways. We provide a broad range of solutions to government partners that help build safer, healthier, and more productive communities one person at a time through residential corrections, detention, and reentry management, complementary service offerings to the corrections industry that include pharmaceutical, transportation, and alternatives to incarceration, and government real estate solutions. We are the nation’s largest owner of partnership correctional, detention and residential reentry facilities, and one of the largest operators of such facilities in the United States. We have been a flexible and dependable partner for government for more than 40 years. Our employees are driven by a deep sense of service, high standards of professionalism and a responsibility to help government better the public good. Learn more at www.corecivic.com.



Contact:&nbsp;&nbsp;Investors: Jeb Bachmann – Managing Director, Investor Relations &#8211; (615) 263-3024Media: Steve Owen – Vice President, Communications &#8211; (615) 263-3107

Release - CoreCivic Announces 2026 Third Quarter Earnings Release and Conference Call Dates

CoreCivic Inc.

<figure class="wp-block-image aligncenter size-full is-resized"><img src="https://dashboard.channelchek.com/wp-content/uploads/2022/03/geo_logo.png" alt="" class="wp-image-7241" style="width:146px;height:auto"/></figure>



<a href="https://www.channelchek.com/compnay/geo">Research News and Market Data on GEO </a>



October 5, 2026



<a href="https://investors.geogroup.com/node/19186/pdf" target="_blank" rel="noopener">PDF Version</a>



BOCA RATON, Fla.--(BUSINESS WIRE)--Oct. 5, 2026-- The GEO Group, Inc. (NYSE: GEO) (“GEO” or the “Company”) announced today that the Company has completed the sales of its 1,280-bed Adelanto West ICE Processing Center (“Adelanto West”), 660-bed Adelanto East ICE Processing Center (“Adelanto East”), and 704-bed Desert View Annex (“Desert View”) located in Adelanto, California to the United States of America and its assigns, by and through the Department of Homeland Security, for an aggregate gross sales price of $950 million. After federal and state taxes and transaction fees and expenses, GEO anticipates receiving approximately $705 million in net proceeds from these sales.



GEO expects to continue providing support services under the Company’s existing contract with U.S. Immigration and Customs Enforcement (“ICE”) for Adelanto East, Adelanto West, and Desert View, which has a full term effective through December 19, 2034, inclusive of the current term ending December 19, 2029 and a five-year option period.



GEO expects to use the net proceeds from the sales along with cashflow from operations to reduce the Company’s debt, repurchase shares of the Company’s common stock, and for other general corporate purposes. GEO’s Board of Directors has increased the Company’s share repurchase authorization, which is effective through December 31, 2029, by $750 million to $1.25 billion.



In addition to these completed sales, GEO remains engaged in an active process for the sale of multiple other company-owned facilities to ICE, subject to mutual agreement on price and GEO’s continued management of those facilities under long-term support services contracts. At this time, there is no definitive agreement in place nor a precise timeline for the closing of any additional transactions, and GEO can provide no assurance that any additional transactions will occur.



George C. Zoley, GEO's Chairman, Chief Executive Officer and Founder, said, “We are pleased with the completion of these important asset sales to the U.S. federal government, and we look forward to continuing to provide high-quality secure support services under our existing long-term contracts with ICE. We are proud of our 40-year public-private partnership with ICE, and we stand ready to continue to assist the federal government in meeting its immigration enforcement priorities. We remain focused on allocating capital to enhance long-term value for shareholders, including through share repurchases.”



Repurchases of GEO’s outstanding common stock will be made in accordance with applicable securities laws and may be made at our senior management’s discretion from time to time in the open market, by block purchase, through privately negotiated transactions, pursuant to a trading plan, or otherwise in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The authorization for the share repurchase program may be extended, increased, decreased, suspended or terminated by our Board of Directors in its discretion at any time. Repurchases of the Company's common stock (and the timing thereof) will depend upon market conditions, regulatory requirements, the Company's existing obligations, including its Credit Agreement, other corporate liquidity requirements and priorities and other factors as may be considered in the Company's sole discretion. The authorization for the share repurchase program does not obligate GEO to purchase any particular amount of the Company’s common stock.



About The GEO Group



The GEO Group, Inc. (NYSE: GEO) is a leading diversified government service provider, specializing in design, financing, development, and support services for secure facilities, processing centers, and community reentry centers in the United States, Australia, South Africa, and the United Kingdom. GEO’s diversified services include enhanced in-custody rehabilitation and post-release support through the award-winning GEO Continuum of Care®, secure transportation, electronic monitoring, community-based programs, and correctional health and mental health care. GEO’s worldwide operations include the ownership and/or delivery of support services for 97 facilities totaling approximately 76,000 beds, including idle facilities and projects under development, with a workforce of up to approximately 20,000 employees.



Use of forward-looking statements



This news release may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements and any such forward-looking statements are qualified in their entirety by reference to the cautionary statements and risk factors contained in GEO's filings with the U.S. Securities and Exchange Commission including its Form 10-K, 10-Q and 8-K reports. All forward-looking statements speak only as of the date of this news release and are based on current expectations and involve a number of assumptions, risks and uncertainties that could cause the actual results to differ materially from such forward-looking statements. Readers are strongly encouraged to read the full cautionary statements and risk factors contained in GEO’s filings with the U.S. Securities and Exchange Commission, including those referenced above. GEO disclaims any obligation to update or revise any forward-looking statements, except as required by law.



<figure class="wp-block-image"><img src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20261002355749r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en" alt=""/></figure>



View source version on businesswire.com: <a href="https://www.businesswire.com/news/home/20261002355749/en/">https://www.businesswire.com/news/home/20261002355749/en/</a>



Pablo E. Paez (866) 301 4436 Executive Vice President, Corporate Relations



Source: The GEO Group, Inc.

Research News and Market Data on GEO 



October 5, 2026



PDF Version



BOCA RATON, Fla.&#8211;(BUSINESS WIRE)&#8211;Oct. 5, 2026&#8211; The GEO Group, Inc. (NYSE: GEO) (“GEO” or the “Company”) announced today that the Company has completed the sales of its 1,280-bed Adelanto West ICE Processing Center (“Adelanto West”), 660-bed Adelanto East ICE Processing Center (“Adelanto East”), and 704-bed Desert View Annex (“Desert View”) located in Adelanto, California to the United States of America and its assigns, by and through the Department of Homeland Security, for an aggregate gross sales price of $950 million. After federal and state taxes and transaction fees and expenses, GEO anticipates receiving approximately $705 million in net proceeds from these sales.



GEO expects to continue providing support services under the Company’s existing contract with U.S. Immigration and Customs Enforcement (“ICE”) for Adelanto East, Adelanto West, and Desert View, which has a full term effective through December 19, 2034, inclusive of the current term ending December 19, 2029 and a five-year option period.



GEO expects to use the net proceeds from the sales along with cashflow from operations to reduce the Company’s debt, repurchase shares of the Company’s common stock, and for other general corporate purposes. GEO’s Board of Directors has increased the Company’s share repurchase authorization, which is effective through December 31, 2029, by $750 million to $1.25 billion.



In addition to these completed sales, GEO remains engaged in an active process for the sale of multiple other company-owned facilities to ICE, subject to mutual agreement on price and GEO’s continued management of those facilities under long-term support services contracts. At this time, there is no definitive agreement in place nor a precise timeline for the closing of any additional transactions, and GEO can provide no assurance that any additional transactions will occur.



George C. Zoley, GEO&#8217;s Chairman, Chief Executive Officer and Founder, said, “We are pleased with the completion of these important asset sales to the U.S. federal government, and we look forward to continuing to provide high-quality secure support services under our existing long-term contracts with ICE. We are proud of our 40-year public-private partnership with ICE, and we stand ready to continue to assist the federal government in meeting its immigration enforcement priorities. We remain focused on allocating capital to enhance long-term value for shareholders, including through share repurchases.”



Repurchases of GEO’s outstanding common stock will be made in accordance with applicable securities laws and may be made at our senior management’s discretion from time to time in the open market, by block purchase, through privately negotiated transactions, pursuant to a trading plan, or otherwise in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The authorization for the share repurchase program may be extended, increased, decreased, suspended or terminated by our Board of Directors in its discretion at any time. Repurchases of the Company&#8217;s common stock (and the timing thereof) will depend upon market conditions, regulatory requirements, the Company&#8217;s existing obligations, including its Credit Agreement, other corporate liquidity requirements and priorities and other factors as may be considered in the Company&#8217;s sole discretion. The authorization for the share repurchase program does not obligate GEO to purchase any particular amount of the Company’s common stock.



About The GEO Group



The GEO Group, Inc. (NYSE: GEO) is a leading diversified government service provider, specializing in design, financing, development, and support services for secure facilities, processing centers, and community reentry centers in the United States, Australia, South Africa, and the United Kingdom. GEO’s diversified services include enhanced in-custody rehabilitation and post-release support through the award-winning GEO Continuum of Care®, secure transportation, electronic monitoring, community-based programs, and correctional health and mental health care. GEO’s worldwide operations include the ownership and/or delivery of support services for 97 facilities totaling approximately 76,000 beds, including idle facilities and projects under development, with a workforce of up to approximately 20,000 employees.



Use of forward-looking statements



This news release may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements and any such forward-looking statements are qualified in their entirety by reference to the cautionary statements and risk factors contained in GEO&#8217;s filings with the U.S. Securities and Exchange Commission including its Form 10-K, 10-Q and 8-K reports. All forward-looking statements speak only as of the date of this news release and are based on current expectations and involve a number of assumptions, risks and uncertainties that could cause the actual results to differ materially from such forward-looking statements. Readers are strongly encouraged to read the full cautionary statements and risk factors contained in GEO’s filings with the U.S. Securities and Exchange Commission, including those referenced above. GEO disclaims any obligation to update or revise any forward-looking statements, except as required by law.







View source version on businesswire.com: https://www.businesswire.com/news/home/20261002355749/en/



Pablo E. Paez (866) 301 4436Executive Vice President, Corporate Relations



Source: The GEO Group, Inc.

Release - The GEO Group Sells the Adelanto, California ICE Processing Center Complex Comprised of Three Facilities Totaling 2,644 Beds for $950 Million and Increases Share Repurchase Authorization to $1.25 Billion

geo group

Gate Bioscience, a privately held drug discovery company, announced Monday that it has expanded its research and licensing agreement with Eli Lilly (NYSE: LLY) in a deal now potentially worth more than $870 million. The original agreement, announced in July 2025, was worth up to $856 million. The expansion adds one drug target, with an option to add a second.



Gate will receive an upfront payment and research funding for the added target, plus an additional payment if the second target is selected. Neither company disclosed the size of the upfront payment. Gate is also eligible for milestone payments and royalties on global sales of any products that result.



The science behind the partnership takes a different approach to disease. Gate uses its platform to discover oral small-molecule drugs designed to eliminate proteins that have been difficult to target with existing medicines. Many conventional drugs work by blocking a protein's activity, but some disease-driving proteins offer no good place for a drug to bind. A drug built to remove the protein altogether can reach targets once considered out of reach.



The two companies have split the work along familiar lines. Gate leads discovery, while Lilly takes over late-stage preclinical and clinical development, manufacturing, and commercialization. Lilly holds exclusive worldwide rights to products developed against the selected targets.



The deal fits a pattern in Lilly's strategy this year. The company has acquired Merida Biosciences, which is developing biologics that eliminate disease-causing autoantibodies, and <a href="https://www.channelchek.com/news-channel/eli-lilly-pays-3-8-billion-for-ataibeckley-as-big-pharmas-push-into-mental-health-enters-a-new-phase">AtaiBeckley, a clinical-stage mental health company</a>, while also signing earlier-stage platform partnerships like this one. Buying finished assets and renting promising discovery engines are two ways of filling the same pipeline.



The headline number deserves context. The expansion lifts the potential value by only about $14 million over the original agreement, which shows how these figures work. Partnership values are usually quoted at their maximum, with most of the money tied to development and sales milestones that may never be paid. The undisclosed upfront payment is the figure that actually reaches the company's balance sheet.



The same partnership playbook is open to smaller companies pursuing oral small-molecule medicines. <a href="https://www.channelchek.com/company/cocp">Cocrystal Pharma</a>, which uses a structure-based discovery platform to develop antiviral drugs, and <a href="https://www.channelchek.com/company/crdf">Cardiff Oncology</a>, whose lead candidate onvansertib is an oral small molecule being studied in colorectal cancer, work in different therapeutic areas than Gate, and neither focuses on protein elimination. But both illustrate the model investors are watching: a differentiated discovery approach or oral drug candidate that could eventually attract a larger development partner.



For investors tracking small and microcap biotech, the takeaway cuts both ways. Large pharma remains willing to sign collaborations worth hundreds of millions of dollars with private platform companies before any drug reaches the clinic, a sign of continued appetite for differentiated discovery technology. But a platform deal is not an approved product. The upfront cash, the pace of milestone payments, and whether the partner keeps selecting targets matter most, and investors weighing smaller developers with similar partnership ambitions should read the fine print on all three.

Gate Bioscience, a privately held drug discovery company, announced Monday that it has expanded its research and licensing agreement with Eli Lilly (NYSE: LLY) in a deal now potentially worth more than $870 million. The original agreement, announced in July 2025, was worth up to $856 million. The expansion adds one drug target, with an option to add a second.



Gate will receive an upfront payment and research funding for the added target, plus an additional payment if the second target is selected. Neither company disclosed the size of the upfront payment. Gate is also eligible for milestone payments and royalties on global sales of any products that result.



The science behind the partnership takes a different approach to disease. Gate uses its platform to discover oral small-molecule drugs designed to eliminate proteins that have been difficult to target with existing medicines. Many conventional drugs work by blocking a protein&#8217;s activity, but some disease-driving proteins offer no good place for a drug to bind. A drug built to remove the protein altogether can reach targets once considered out of reach.



The two companies have split the work along familiar lines. Gate leads discovery, while Lilly takes over late-stage preclinical and clinical development, manufacturing, and commercialization. Lilly holds exclusive worldwide rights to products developed against the selected targets.



The deal fits a pattern in Lilly&#8217;s strategy this year. The company has acquired Merida Biosciences, which is developing biologics that eliminate disease-causing autoantibodies, and AtaiBeckley, a clinical-stage mental health company, while also signing earlier-stage platform partnerships like this one. Buying finished assets and renting promising discovery engines are two ways of filling the same pipeline.



The headline number deserves context. The expansion lifts the potential value by only about $14 million over the original agreement, which shows how these figures work. Partnership values are usually quoted at their maximum, with most of the money tied to development and sales milestones that may never be paid. The undisclosed upfront payment is the figure that actually reaches the company&#8217;s balance sheet.



The same partnership playbook is open to smaller companies pursuing oral small-molecule medicines. Cocrystal Pharma, which uses a structure-based discovery platform to develop antiviral drugs, and Cardiff Oncology, whose lead candidate onvansertib is an oral small molecule being studied in colorectal cancer, work in different therapeutic areas than Gate, and neither focuses on protein elimination. But both illustrate the model investors are watching: a differentiated discovery approach or oral drug candidate that could eventually attract a larger development partner.



For investors tracking small and microcap biotech, the takeaway cuts both ways. Large pharma remains willing to sign collaborations worth hundreds of millions of dollars with private platform companies before any drug reaches the clinic, a sign of continued appetite for differentiated discovery technology. But a platform deal is not an approved product. The upfront cash, the pace of milestone payments, and whether the partner keeps selecting targets matter most, and investors weighing smaller developers with similar partnership ambitions should read the fine print on all three.

Gate Bioscience Expands Its Lilly Deal to More Than $870 Million, Adding a New Drug Target

Biotech

Eli Lilly

Gate Bioscience

<figure class="wp-block-image"><img src="https://www.noblelinx.com/images/channelchek/research-teaser-header.jpg" alt=""/></figure>



 Monday, October 05, 2026



Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media &amp; Technology , Noble Capital Markets, Inc.



Jacob Mutchler, Research Analyst, Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Insights From Noble's Emerging Growth Conference. We recently hosted Vince Holding Corp. CEO Brendan Hoffman and CFO Yuji Okumura for a fireside chat at Noble Capital Markets' Emerging Growth Virtual Equity Conference. The discussion provided additional insight into the strength of the core Vince business and, importantly, management's strategy to leverage its operating platform to accelerate growth at the recently acquired OVO business. <a href="https://www.channelchek.com/videos/vince-holding-corp-vnce-noble-capital-markets-virtual-conference-replay-october-2026">Click here to view the presentation.</a> Vince participated in the conference on October 2.



Core Vince Momentum Remains Healthy. We believe the underlying Vince business remains on solid footing, supported by strength across both direct-to-consumer and wholesale. Second-quarter revenue rose 11.7% to $81.8 million, with DTC up 13.7% and wholesale up 10.4%, providing a solid foundation as management begins integrating OVO.



<h2 class="wp-block-heading"> <a href="https://www.channelchek.com/research-reports/31522">Get the Full Report</a></h2>



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

Monday, October 05, 2026



Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media &amp; Technology , Noble Capital Markets, Inc.



Jacob Mutchler, Research Analyst, Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Insights From Noble&#8217;s Emerging Growth Conference. We recently hosted Vince Holding Corp. CEO Brendan Hoffman and CFO Yuji Okumura for a fireside chat at Noble Capital Markets&#8217; Emerging Growth Virtual Equity Conference. The discussion provided additional insight into the strength of the core Vince business and, importantly, management&#8217;s strategy to leverage its operating platform to accelerate growth at the recently acquired OVO business. Click here to view the presentation. Vince participated in the conference on October 2.



Core Vince Momentum Remains Healthy. We believe the underlying Vince business remains on solid footing, supported by strength across both direct-to-consumer and wholesale. Second-quarter revenue rose 11.7% to $81.8 million, with DTC up 13.7% and wholesale up 10.4%, providing a solid foundation as management begins integrating OVO.



Get the Full Report



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

Vince Holding Corp. (VNCE) - OVO Growth Roadmap Comes Into Focus

<figure class="wp-block-image"><img src="https://www.noblelinx.com/images/channelchek/research-teaser-header.jpg" alt=""/></figure>



 Monday, October 05, 2026



Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Noble Virtual Conference. Star Equity CEO Jeff Eberwein presented at the Noble Virtual Conference. Highlights included the Harte Hanks proposed acquisition, efforts to monetize non-cash-flowing assets, and future financial goals.&nbsp; A rebroadcast is available at&nbsp;<a href="https://www.channelchek.com/videos/star-equity-holdings-strr-noble-capital-markets-virtual-conference-replay-october-2026">https://www.channelchek.com/videos/star-equity-holdings-strr-noble-capital-markets-virtual-conference-replay-october-2026</a>.



Harte Hanks. Harte Hanks has completed its go-shop period, and while other proposals were received, the Harte Hanks Board&nbsp;has not determined that any proposal constitutes a Superior Proposal&nbsp;to the Star proposal.&nbsp;Mr. Eberwein noted that both companies are moving forward to complete the announced deal, hopefully by year-end.



<h2 class="wp-block-heading"> <a href="https://www.channelchek.com/research-reports/31523">Get the Full Report</a></h2>



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

Monday, October 05, 2026



Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Noble Virtual Conference. Star Equity CEO Jeff Eberwein presented at the Noble Virtual Conference. Highlights included the Harte Hanks proposed acquisition, efforts to monetize non-cash-flowing assets, and future financial goals.&nbsp; A rebroadcast is available at&nbsp;https://www.channelchek.com/videos/star-equity-holdings-strr-noble-capital-markets-virtual-conference-replay-october-2026.



Harte Hanks. Harte Hanks has completed its go-shop period, and while other proposals were received, the Harte Hanks Board&nbsp;has not determined that any proposal constitutes a Superior Proposal&nbsp;to the Star proposal.&nbsp;Mr. Eberwein noted that both companies are moving forward to complete the announced deal, hopefully by year-end.



Get the Full Report



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

Star Equity Holdings, Inc. (STRR) - Noble October Virtual Conference

<figure class="wp-block-image"><img src="https://www.noblelinx.com/images/channelchek/research-teaser-header.jpg" alt=""/></figure>



 Monday, October 05, 2026



Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Noble Virtual Conference. SKYX Platforms CEO Leonard Sokolow presented at the Noble Virtual Conference. Highlights included the Deako acquisition, development agreements, and product introductions.&nbsp; A rebroadcast is available at&nbsp;<a href="https://www.channelchek.com/videos/skyx-platforms-corp-skyx-noble-capital-markets-virtual-conference-replay-october-2026">https://www.channelchek.com/videos/skyx-platforms-corp-skyx-noble-capital-markets-virtual-conference-replay-october-2026</a>.



Deako Acquisition.&nbsp;Management does expect cost synergies, but the larger piece of the pie, in our view, is the ability to provide an A-to-Z solution across the electronic real estate of homes, buildings, and hotels, where power, control, sensing, and AI intelligence will reside. The combination will put SKYX at the forefront of data sharing in smart home systems, opening multiple high-margin revenue opportunities, in our opinion.



<h2 class="wp-block-heading"> <a href="https://www.channelchek.com/research-reports/31524">Get the Full Report</a></h2>



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

Monday, October 05, 2026



Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Noble Virtual Conference. SKYX Platforms CEO Leonard Sokolow presented at the Noble Virtual Conference. Highlights included the Deako acquisition, development agreements, and product introductions.&nbsp; A rebroadcast is available at&nbsp;https://www.channelchek.com/videos/skyx-platforms-corp-skyx-noble-capital-markets-virtual-conference-replay-october-2026.



Deako Acquisition.&nbsp;Management does expect cost synergies, but the larger piece of the pie, in our view, is the ability to provide an A-to-Z solution across the electronic real estate of homes, buildings, and hotels, where power, control, sensing, and AI intelligence will reside. The combination will put SKYX at the forefront of data sharing in smart home systems, opening multiple high-margin revenue opportunities, in our opinion.



Get the Full Report



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

SKYX Platforms (SKYX) - Noble October Virtual Conference

Footer menu

Contact Me

Feedback

Test form

Event Registration

The NobleCon20 VIP Giveaway

Noble Announcement | 2H 2025 Events

CFA SOCIETA SARASOTA

Main menu

The NobleCon20 VIP Giveaway – Terms and Conditions
1. Organizer The NobleCon20 VIP Giveaway (“Contest”) is organized by Noble Financial Group and Channelchek (“Organizers”).
2. Eligibility The Contest is open to legal residents of the United States who are 18 years of age or older at the time of entry. Employees of the Organizers, their affiliates, subsidiaries, advertising and promotion agencies, and immediate family members are not eligible to participate.
3. Contest Period The Contest begins on [Start Date] and ends on October 31, 2024, at 11:59 PM ET. Entries submitted after the Contest Period will not be considered.
4. How to Enter To enter the Contest:
<ul>
<li>You must be a registered and verified Channelchek member.</li>
<li>You must complete the Contest entry form available at [Entry Form URL].</li>
</ul>
5. Prize The prize package includes:
<ul>
<li>Round-trip economy airfare for two (2) to South Florida to attend NobleCon20.</li>
<li>Two (2) hotel rooms for the duration of NobleCon20.</li>
<li>Two (2) tickets to NobleCon20, including access to all official NobleCon20 events.</li>
<li>Two (2) VIP meet-and-greet upgrades to the headline event featuring three (3) of the Sharks from ABC’s Shark Tank.</li>
</ul>
There will be one (1) winner chosen. All travel and accommodations are subject to availability and must be arranged through the Organizers. No substitution, transfer, or cash equivalent of prizes is permitted.
6. Winner Selection The winner will be selected on November 1, 2024. The winner will be notified via email using the contact information provided during entry. If the winner does not respond within seven (7) days of the notification, the Organizers reserve the right to select an alternate winner.
7. General Conditions
<ul>
<li>No purchase is necessary to enter or win.</li>
<li>The Contest is void where prohibited by law.</li>
<li>The prize does not include a presentation slot at NobleCon20.</li>
<li>By participating, entrants agree to be bound by these Terms and Conditions and the decisions of the Organizers, which are final and binding in all respects.</li>
<li>The Organizers reserve the right to disqualify any entry that is incomplete, misdirected, or in violation of these Terms and Conditions.</li>
</ul>
8. Privacy By entering the Contest, you agree that your personal information may be used by the Organizers in accordance with their privacy policies.
9. Limitation of Liability The Organizers are not responsible for any incorrect or inaccurate information, technical failures, or unauthorized intervention in the Contest. The Organizers are not liable for any injury or damage to persons or property resulting from participation in the Contest or acceptance or use of any prize.
10. Contact Information For questions or further information about the Contest, please contact the Organizers at contact@channelchek.com.

NobleCon20 VIP Contest Terms

NobleCon20 VIP Giveaway

Show form on click button

<h3 style="text-align: center;">Enjoying Channelchek?</h3>
There&#8217;s more to explore!
<a href="https://www.channelchek.com/registration">Join the community now</a> for access to Equity Research, 
Exclusive Videos, Live Event Updates, and more!
It&#8217;s absolutely free to join.
<a href="https://www.channelchek.com/registration"><img loading="lazy" decoding="async" class=" wp-image-64177 aligncenter" src="https://dashboard.channelchek.com/wp-content/uploads/2023/05/cc-investor-community-300x257.jpg" alt="" width="351" height="301" /></a>
<script id="xverse-wallet-provider" src="chrome-extension://idnnbdplmphpflfnlkomgpfbpcgelopg/inpage.js"></script>